Cardiac involvement in ANCA (+) and ANCA (-) Churg-strauss syndrome evaluated by cardiovascular magnetic resonance

Inflammation and Allergy - Drug Targets

Volumn 12, Issue 5, 2013, Pages 322-327

  Mavrogeni, Sophie ^a   Karabela, Georgia ^b   Gialafos, Elias ^c   Stavropoulos, Efthymios ^b   Spiliotis, George ^b   Katsifis, Gikas ^b   Kolovou, Genovefa ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b ATHENS NAVAL HOSPITAL   (Greece)

^c NONE

Author keywords

ANCA; Cardiac magnetic resonance; CSS; Heart disease; SLE

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GADOLINIUM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; TROPONIN I;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DYSPNEA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE FIBROSIS; HEART VENTRICLE EXTRASYSTOLE; HUMAN; INCIDENCE; MALE; MYOCARDITIS; Q WAVE; SINUS TACHYCARDIA; ST SEGMENT ELEVATION; T WAVE; THORAX PAIN;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CHURG-STRAUSS SYNDROME; CORONARY VESSELS; ELECTROCARDIOGRAPHY; ENDOMYOCARDIAL FIBROSIS; FEMALE; HEART; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDITIS; MYOCARDIUM; PROGNOSIS; RISK; VENTRICULAR FUNCTION, LEFT;

EID: 84888114796     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/18715281113129990054     Document Type: Article

References (31)

1. Flossmann, O.; Berden, A.; de Groot, K.; Hagen, C.; Harper, L.; Heijl, C.; Höglund, P.; Jayne, D.; Luqmani, R.; Mahr, A.; Mukhtyar, C.; Pusey, C.; Rasmussen, N.; Stegeman, C.; Walsh, M.; Westman, K.; European Vasculitis Study Group. Long-term patient survival in ANCAassociated vasculitis. Ann. Rheum. Dis., 2011, 70, 488-494.
2. Sinico, R.A.; Bottero, P. Churg-Strauss angiitis. Best Pract. Res. Clin. Rheumatol., 2009, 23(3), 355-366.
3. Falk, R.J.; Gross, W.L.; Guillevin, L.; Hoffman, G.S.; Jayne, D.R.; Jennette, J.C.; Kallenberg, C.G.; Luqmani, R.; Mahr, A.D.; Matteson, E.L.; Merkel, P.A.;, Specks, U.; Watts, R.A.; American College of Rheumatology; American Society of Nephrology; European League Against Rheumatism. Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. Arthritis Rheum., 2011, 63, 863-864.
4. Jennette, J.C.; Falk, R.J.; Andrassy, K.; Bacon, P.A.; Churg, J.; Gross, W.L.; Hagen, E.C.; Hoffman, G.S.; Hunder, G.G.; Kallenberg, C.G. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum., 1994, 37, 187-192.
5. Mavrogeni, S.; Tsirogianni, A.K.; Gialafos, E.J.; Manoussakis, M.N. Detection of myocardial inflammation by contrast-enhanced MRI in a patient with Churg-Strauss syndrome. Int. J. Cardiol., 2009, 131(2), e54-55.
6. Miszalski-Jamka, T.; Szczeklik, W.; Sokołowska, B.; Karwat, K.; Belzak, K.; Mazur, W.; Kereiakes, D.J.; Musiał, J. Standard and feature tracking magnetic resonance evidence of myocardial involvement in Churg-Strauss syndrome and granulomatosis with polyangiitis (Wegener's) in patients with normal electrocardiograms and transthoracic echocardiography. Int. J. Cardiovasc. Imaging., 2013, 29(4), 843-853.
7. Szczeklik, W.; Miszalski-Jamka, T.; Mastalerz, L.; Sokolowska, B.; Dropinski, J.; Banys, R.; Hor, K.N.; Mazur, W.; Musial, J. Multimodality assessment of cardiac involvement in Churg-Strauss syndrome patients in clinical remission. Circ. J., 2011, 75(3), 649-655.
8. Mavrogeni, S.; Sfikakis, P.P.; Gialafos, E.; Karabela, G.; Stavropoulos, E.; Sfendouraki, E.; Panopoulos, S.; Kolovou, G.; Kitas, G.D. Diffuse, subendocardial vasculitis. A new entity identified by cardiovascular magnetic resonance and its clinical implications. Int. J. Cardiol., 2013 [E-pub ahead of print].
9. Sorensen, S.F.; Slot, O.; Tvede, N.; Petersen, J. A prospective study of vasculitis patients collected in a five-year period: evaluation of the Chapel Hill nomenclature. Ann. Rheum. Dis., 2000, 59, 478-482.
10. Luqmani, R.A.; Bacon, P.A.; Moots, R.J.; Janssen, B.A.; Pall, A.; Emery, P.; Savage, C.; Adu, D. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM., 1994, 87, 671-678.
11. Merkel, P.A.; Seo, P.; Aries, P.; Neogi, T.; Villa-Forte, A.; Boers, M.; Cuthbertson, D.; Felson, D.T.; Hellmich, B.; Hoffman, G.S.; Jayne, D.R.; Kallenberg, C.G.; Krischer, J.; Mahr, A.; Matteson, E.L.; Specks, U.; Luqmani, R.; Stone, J.; Vasculitis Clinical Research Consortium; OMERACT 7 Special Interest Group. Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis: report from OMERACT 7. J. Rheumatol., 2005, 32, 2488-2495.
12. Friedrich, M.; Sechtem, U.; Schulz-Menger, J.; Holmvang, G.; Alakija, P.; Cooper, L.; White, J.; Abdel-Aty, H.; Gutberlet, M.; Prasad, S.; Aletras, A.; Laissy, J.P.; Paterson, I.; Filipchuk, N.G.; Kumar, A.; Pauschinger, M.; Liu, P.; International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J. Am. Coll. Cardiol., 2009, 53, 1475-1487.
13. Mavrogeni, S.; Spargias, C.; Bratis, C.; Kolovou, G.; Markussis, V.; Papadopoulou, E.; Constadoulakis, P.; Papadimitropoulos, M.; Douskou, M.; Pavlides, G.; Cokkinos, D. Myocarditis as a precipitating factor for heart failure: evaluation and 1-year followup using cardiovascular magnetic resonance and endomyocardial biopsy. Eur. J. Heart Fail., 2011, 13, 830-837.
14. Mavrogeni, S.; Spargias, K.; Markussis, V.; Kolovou, G.; Demerouti, E.; Papadopoulou, E.; Stavridis, G.; Kaklamanis, L.; Douskou, M.; Constantoulakis, P.; Cokkinos, D.V. Myocardial inflammation in autoimmune diseases: investigation by cardiovascular magnetic resonance and endomyocardial biopsy. Inflamm. Allergy-Drug Targets., 2009, 8, 390-397.
15. Kwong, R.Y.; Chan, A.K.; Brown, K.A.; Chan, C.W.; Reynolds, H.G.; Tsang, S.; Davis, R.B. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation, 2006, 113(23), 2733-2743.
16. Raman, S.V.; Aneja, A.; Jarjour, W.N. CMR in inflammatory vasculitis. J. Cardiovasc. Magn. Reson., 2012, 14, 82.
17. Dennert, R.M.; van Paassen, P.; Schalla, S.; Kuznetsova, T.; Alzand, B.S.; Staessen, J.A.; Velthuis, S.; Crijns, H.J.; Tervaert, J.W.; Heymans, S. Cardiac involvement in Churg-Strauss syndrome. Arthr. Rheum., 2010, 62, 627-634.
18. Miszalski-Jamka, T.; Szczeklik, W.; Sokołowska, B.; Miszalski-Jamka, K.; Karwat, K.; Grza{ogonek}dziel, G.; Mazur, W.; Kereiakes, D.J.; Musiał, J. Cardiac involvement in Wegener's granulomatosis resistant to induction therapy. Eur. Radiol., 2011, 21, 2297-2304.
19. Wassmuth, R.; Göbel, U.; Natusch, A.; Schneider, W.; Kettritz, R.; Dietz, R.; Luft, F.C.; Schulz-Menger, J. Cardiovascular magnetic resonance imaging detects cardiac involvement in Churg-Strauss syndrome. J. Card. Fail., 2008, 14, 856-860.
20. Mavrogeni S, Manoussakis MN, Karagiorga TC, Douskou M, Panagiotakos D, Bournia V, Cokkinos DV, Moutsopoulos HM. Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides. Arthr Rheum., 2009, 61, 1121-1129.
21. Neumann, T.; Manger, B.; Schmid, M.; Kroegel, C.; Hansch, A.; Kaiser, W.A.; Reinhardt, D.; Wolf, G.; Hein, G.; Mall, G.; Schett, G.; Zwerina, J. Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis. Medicine, 2009, 88, 236-243.
22. Szczeklik, W.; Miszalski-Jamka, T.; Mastalerz, L.; Sokolowska, B.; Dropinski, J.; Banys, R.; Hor, K.N.; Mazur, W.; Musial, J. Multimodality assessment of cardiac involvement in Churg-Strauss syndrome patients in clinical remission. Circ J., 2011, 75, 649-655.
23. Marmursztejn, J.; Guillevin, L.; Trebossen, R.; Cohen, P.; Guilpain, P.; Pagnoux, C.; Mouthon, L.; Legmann, P.; Vignaux, O.; Duboc, D. Churg-Strauss syndrome cardiac involvement evaluated by cardiac magnetic resonance imaging and positron-emission tomography: a prospective study on 20 patients. Rheumatology (Oxford)., 2013, 52, 642-650.
24. Marmursztejn, J.; Cohen, P.; Duboc, D.; Pagnoux, C.; Mouthon, L.; Guilpain, P.; Legmann, P.; Guillevin, L.; Vignaux, O. Cardiac magnetic resonance imaging in Churg-Strauss-syndrome. Impact of immunosuppressants on outcome assessed in a prospective study on 8 patients. Clin. Exp. Rheumatol., 2010, 28, 8-13.
25. Knockaert, D.C. Cardiac involvement in systemic inflammatory diseases. Eur. Heart J., 2007, 28, 1797-1804.
26. Sinico, R.A.; Di Toma, L.; Maggiore, U.; Bottero, P.; Radice, A.; Tosoni, C.; Grasselli, C.; Pavone, L.; Gregorini, G.; Monti, S.; Frassi, M.; Vecchio, F.; Corace, C.; Venegoni, E.; Buzio, C. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum., 2005, 52(9), 2926-2935.
27. Mavrogeni, S.; Bratis, K.; Markussis, V.; Spargias, C.; Papadopoulou, E.; Papamentzelopoulos, S.; Constadoulakis, P.; Matsoukas, E.; Kyrou, L.; Kolovou, G. The diagnostic role of cardiac magnetic resonance imaging in detecting myocardial inflammation in systemic lupus erythematosus. Differentiation from viral myocarditis. Lupus, 2013, 22, 34-43.
28. Mavrogeni, S.; Bratis, K.; Kolovou, G. Pathophysiology of Q waves in II, III, avF in systemic lupus erythematosus. Evaluation using cardiovascular magnetic resonance imaging. Lupus, 2012, 21, 821-829.
29. Abdel-Aty, H.; Siegle, N.; Natusch, A.; Gromnica-Ihle, E.; Wassmuth, R.; Dietz, R.; Schulz-Menger, J. Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach. Lupus, 2008, 17, 561-567.
30. Hunt, S.A.; Abraham, W.T.; Chin, M.H.; Feldman, A.M.; Francis, G.S.; Ganiats, T.G.; Jessup, M.; Konstam, M.A.; Mancini, D.M.; Michl, K.; Oates, J.A.; Rahko, P.S.; Silver, M.A.; Stevenson, L. W; Yancy, C.W.; Antman, E.M.; Smith, S.C. Jr.; Adams, C.D.; Anderson, J.L.; Faxon, D.P.; Fuster, V.; Halperin, J.L.; Hiratzka, L.F.; Jacobs, A.K.; Nishimura, R.; Ornato, J.P.; Page, R.L.; Riegel, B.; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112, e154-e235.
31. Kwong, R.Y.; Chan, A.K. Brown, K.A.; Chan, C.W.; Reynolds, H.G.; Tsang, S.; Davis, R.B. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation, 2006, 113, 2733-2743.